Skip to main content

Advertisement

SpringerLink
Log in

Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Tumour necrosis factor alpha inhibitors, both infliximab and adalimumab, have been approved for the treatment of both rheumatoid arthritis and Crohn’s disease. A slight increase in the risk of infections in patients receiving immunosuppressants and/or biological agents has been reported. Here, we present the case of a 68-year-old woman affected by Crohn’s disease, myasthenia gravis, recurrent uveitis and rheumatoid arthritis who developed pneumonia during concomitant treatment with biological agents and conventional immunosuppressive drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Scott DL, Kingsley GH (2006) Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 355:704–712. doi:10.1056/NEJMct055183

    Article  PubMed  CAS  Google Scholar 

  2. Danese S, Pagano N, Angelucci E et al (2007) Tumor necrosis factor-alpha monoclonal antibodies for Crohn’s disease: tipping the balance. Curr Med Chem 14:1489–1497. doi:10.2174/092986707780831104

    Article  PubMed  CAS  Google Scholar 

  3. Bonghartz T, Sutton AJ, Sweeting MG et al (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275–2285. doi:10.1001/jama.295.19.2275

    Article  Google Scholar 

  4. Lichtenstein GR, Feagan BG, Cohen RD et al (2006) Serious infections and mortality in association with therapies for crn’s disease: TREAT registry. Clin Gastroenterol Hepatol 4:621–630. doi:10.1016/j.cgh.2006.03.002

    Article  PubMed  CAS  Google Scholar 

  5. Parra MI, Martinez MC, Remacha MA et al (2008) Pneumonia due to Nocardia cyriacigeorgica in a patient with Crohn’s disease treated with infliximab. J Crohn’s Colitis 2:331–332. doi:10.1016/j.crohns.2008.05.003

    Article  Google Scholar 

  6. Kakoulidou M, Bjelak S, Pirskanen R et al (2007) A clinical and immunological study of a myasthenia gravis patient treated with infliximab. Acta Neurol Scand 115:279–283. doi:10.1111/j.1600-0404.2006.00778.x

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Unit, University of Rome “Sapienza”, Viale del Policlinico 155, 00161, Rome, Italy

    Erika Angelucci, Monica Cesarini & Piero Vernia

Authors
  1. Erika Angelucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Cesarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Piero Vernia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erika Angelucci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angelucci, E., Cesarini, M. & Vernia, P. Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs. Rheumatol Int 30, 977–978 (2010). https://doi.org/10.1007/s00296-009-1012-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1012-6

Keywords

Search

Navigation